Financials
- Market Capitalization 3.36 B
- Employee 624
- Founded 2009
- CEO Chad Robins
- Website www.adaptivebiotech.com
- Headquarter Washington, United States
- FIGI BBG001J2PFF5
- Industry 생명공학
총매출
순이익
주당 순이익(기본 EPS)
총부채
잉여 현금 흐름
현금 및 현금성 자산
주가수익비율
-41.64
주가매출액비율
8.9
Related tickers
| # | 이름 | 가격 | 24h % | 7d % | 1M % | 1Y % | 마켓 캡 | 이전 7일 | |
|---|---|---|---|---|---|---|---|---|---|
| 1614 | ARQT Arcutis Biotherapeutics, Inc. - Common stock | 27.12 USD | -2.24% | +3.12% | +10.15% | +70.14% | 3.39 B USD | ||
| 1617 | DYN Dyne Therapeutics, Inc. - Common Stock | 23.64 USD | +0.94% | +3.68% | +28.06% | +0.98% | 3.38 B USD | ||
| 1641 | RARE Ultragenyx Pharmaceutical Inc. - Common Stock | 33.22 USD | -1.77% | -7.54% | +34.93% | +13.22% | 3.27 B USD | ||
| 1661 | BEAM Beam Therapeutics Inc. - Common Stock | 31.00 USD | -5.14% | -15.07% | +3.85% | +45.27% | 3.19 B USD |